Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska

Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska

epi.alaska.gov
from epi.alaska.gov More from this publisher
23.06.2013 Views

References 1 ATS, CDC, IDSA. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(No. RR-12):15. 2 ATS, CDC, IDSA. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(No. RR-12):40. 3 CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6):1. 4 CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005;54(No. RR-17):4–5; CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6):7–9, 22. 5 CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6):8–9. 6 CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6):1–2. 7 CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6):1. 8 ATS, CDC, IDSA. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(No. RR-12):40. 9 ATS, CDC, IDSA. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(No. RR-12):40. 10 ATS, CDC, IDSA. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(No. RR-12):40. 11 CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005;54(No. RR-17):10. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Targeted Testing for Latent Tuber culosis Infection 3.9 R e v i s e d N o v e m b e r 2 0 1 2

B Notifications CONTENTS Introduction ............................................. 4.2 Purpose................................................................ 4.2 Pre-arrival medical screening for tuberculosis ..... 4.2 Overseas screening of applicants for immigration .......................................................... 4.4 Policy ................................................................... 4.6 Follow-up of B1 and B2 Tuberculosis Arrivals ............................. 4.7 Division of Global Migration and Quarantine forms .................................................................... 4.7 Electronic disease notification process overview ............................................................... 4.7 Patient follow-up .................................................. 4.8 Evaluation of B1, B2, and B Tuberculosis Arrivals ............................. 4.9 Evaluation activities ............................................. 4.9 Treatment ........................................................... 4.11 Resources and References ................. 4.12 A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L B Notifications 4.1 Revised November 2012

B Notifications<br />

CONTENTS<br />

Introduction ............................................. 4.2<br />

Purpose................................................................ 4.2<br />

Pre-arrival medical screening for tuberculosis ..... 4.2<br />

Overseas screening <strong>of</strong> applicants for<br />

immigration .......................................................... 4.4<br />

Policy ................................................................... 4.6<br />

Follow-up <strong>of</strong> B1 and B2<br />

<strong>Tuberculosis</strong> Arrivals ............................. 4.7<br />

Division <strong>of</strong> Global Migration and Quarantine<br />

forms .................................................................... 4.7<br />

Electronic disease notification process<br />

overview ............................................................... 4.7<br />

Patient follow-up .................................................. 4.8<br />

Evaluation <strong>of</strong> B1, B2, and B<br />

<strong>Tuberculosis</strong> Arrivals ............................. 4.9<br />

Evaluation activities ............................................. 4.9<br />

Treatment ........................................................... 4.11<br />

Resources and References ................. 4.12<br />

A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L B Notifications 4.1<br />

Revised November 2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!